CHM chimeric therapeutics limited

News: CHM Chimeric Therapeutics Says Obtained Exclusive Option To License Core-Nk Platform

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Dec 1 (Reuters) - Chimeric Therapeutics Ltd (CHM) :

    • OBTAINED EXCLUSIVE OPTION TO LICENSE CORE-NK PLATFORM FROM CASE WESTERN RESERVE UNIVERSITY
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $20.21K 5.053M

Buyers (Bids)

No. Vol. Price($)
2 2213046 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 13563373 20
View Market Depth
Last trade - 15.01pm 24/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.